Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

5.35
Delayed Data
As of 3:21pm ET
 +0.38 / +7.65%
Today’s Change
4.89
Today|||52-Week Range
22.50
-59.83%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.97
Today’s open5.00
Day’s range4.97 - 5.60
Volume264,470
Average volume (3 months)111,570
Market cap$112.1M
Dividend yield--
Data as of 3:21pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)+73.04%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.64

Competitors

 Today’s
change
Today’s
% change
NVLNNovelion Therapeutic...-0.04-1.98%
AVXLAnavex Life Sciences...-0.02-0.52%
ARWRArrowhead Pharmaceut...+0.11+8.33%
PRTOProteon Therapeutics...+0.15+1.58%
Data as of 3:32pm ET, 12/02/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs